HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor
- PMID: 15916966
- DOI: 10.1016/j.molcel.2005.04.021
HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor
Abstract
The molecular chaperone heat shock protein 90 (Hsp90) and its accessory cochaperones function by facilitating the structural maturation and complex assembly of client proteins, including steroid hormone receptors and selected kinases. By promoting the activity and stability of these signaling proteins, Hsp90 has emerged as a critical modulator in cell signaling. Here, we present evidence that Hsp90 chaperone activity is regulated by reversible acetylation and controlled by the deacetylase HDAC6. We show that HDAC6 functions as an Hsp90 deacetylase. Inactivation of HDAC6 leads to Hsp90 hyperacetylation, its dissociation from an essential cochaperone, p23, and a loss of chaperone activity. In HDAC6-deficient cells, Hsp90-dependent maturation of the glucocorticoid receptor (GR) is compromised, resulting in GR defective in ligand binding, nuclear translocation, and transcriptional activation. Our results identify Hsp90 as a target of HDAC6 and suggest reversible acetylation as a unique mechanism that regulates Hsp90 chaperone complex activity.
Similar articles
-
Enhancement of stress resilience through histone deacetylase 6-mediated regulation of glucocorticoid receptor chaperone dynamics.Biol Psychiatry. 2015 Feb 15;77(4):345-55. doi: 10.1016/j.biopsych.2014.07.036. Epub 2014 Aug 28. Biol Psychiatry. 2015. PMID: 25442004 Free PMC article.
-
Modulating molecular chaperone Hsp90 functions through reversible acetylation.Trends Cell Biol. 2005 Nov;15(11):565-7. doi: 10.1016/j.tcb.2005.09.003. Epub 2005 Sep 30. Trends Cell Biol. 2005. PMID: 16199163
-
Regulation of the dynamics of hsp90 action on the glucocorticoid receptor by acetylation/deacetylation of the chaperone.J Biol Chem. 2005 Oct 7;280(40):33792-9. doi: 10.1074/jbc.M506997200. Epub 2005 Aug 8. J Biol Chem. 2005. PMID: 16087666
-
HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination.Oncogene. 2007 Aug 13;26(37):5468-76. doi: 10.1038/sj.onc.1210614. Oncogene. 2007. PMID: 17694087 Review.
-
HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions.Trends Cell Biol. 2008 Jun;18(6):291-7. doi: 10.1016/j.tcb.2008.04.003. Epub 2008 May 9. Trends Cell Biol. 2008. PMID: 18472263 Review.
Cited by
-
New insights into the androgen-targeted therapies and epigenetic therapies in prostate cancer.Prostate Cancer. 2011;2011:918707. doi: 10.1155/2011/918707. Epub 2011 Oct 12. Prostate Cancer. 2011. PMID: 22111003 Free PMC article.
-
Loss of HDAC6, a novel CHIP substrate, alleviates abnormal tau accumulation.Hum Mol Genet. 2012 Jul 1;21(13):2936-45. doi: 10.1093/hmg/dds125. Epub 2012 Apr 5. Hum Mol Genet. 2012. PMID: 22492994 Free PMC article.
-
Attenuation of choroidal neovascularization by histone deacetylase inhibitor.PLoS One. 2015 Mar 25;10(3):e0120587. doi: 10.1371/journal.pone.0120587. eCollection 2015. PLoS One. 2015. PMID: 25807249 Free PMC article.
-
Discovery of Novel Multiacting Topoisomerase I/II and Histone Deacetylase Inhibitors.ACS Med Chem Lett. 2015 Jan 14;6(3):239-43. doi: 10.1021/ml500327q. eCollection 2015 Mar 12. ACS Med Chem Lett. 2015. PMID: 25815139 Free PMC article.
-
Analyzing gene expression profile in K562 cells exposed to sodium valproate using microarray combined with the connectivity map database.J Biomed Biotechnol. 2012;2012:654291. doi: 10.1155/2012/654291. Epub 2012 Jun 4. J Biomed Biotechnol. 2012. PMID: 22701306 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
